Oxalo Therapeutics, Inc. — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for Oxalo Therapeutics, Inc., built entirely from public federal award records. Free competitive intelligence — no login required.
- 3 awards
- $1,524,992 total on record
- 2 agencies
- 2 Phase I · 1 Phase II
Phase mix
- Phase I — 2 awards
- Phase II — 1 award
Funding agencies
Awards by year
- 2022 — 1 award
- 2019 — 1 award
- 2018 — 1 award
Places of performance
Firms like Oxalo Therapeutics, Inc.
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 2200058 | National Science Foundation | $999,999 | STTR · Phase II | 2022-04-15 |
| 1914232 | National Science Foundation | $224,995 | STTR · Phase I | 2019-07-01 |
| 1R42DK120261-01 | Department of Health and Human Services | $299,998 | STTR · Phase I | 2018-09-19 |
Frequently asked questions
How many SBIR/STTR awards has Oxalo Therapeutics, Inc. won?
Oxalo Therapeutics, Inc. has won 3 SBIR/STTR awards worth $1,524,992 in the public federal award records SBIR Signal tracks, including 2 Phase I and 1 Phase II award(s).
Which agencies fund Oxalo Therapeutics, Inc.?
Oxalo Therapeutics, Inc.'s awards come from 2 agencies on record; its top funder is National Science Foundation.
What technology areas does Oxalo Therapeutics, Inc. work in?
Based on its award history, Oxalo Therapeutics, Inc. works in a range of technology areas.
How do I find firms similar to Oxalo Therapeutics, Inc.?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.